Supply Issues PDI (EMEA) Ltd Skin Disinfectant Biocide DEC85019 (ICN 3423)

• The supply issue with skin disinfectant biocide from PDI (EMEA) Limited is continuing.
• One product remains subject to Protect Demand Management:
  • DEC85019 – Skin Disinfectant BIOCIDE 1.6ml swabstick 2% chlorhexidine in 70% alcohol 50 per pack.
• One product remains affected in total.
• DEC85019 is still available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives and for a full list of product codes subject to Protect Demand Management.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. Alternative products MRB306 and DMD85006 are also subject to Protect Demand Management. Updates for these two products can be found on ICN 3397.
• See our Useful Links section to view ICN 3397 for more information on the alternatives.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is anticipated to be resolved by 11 January 2027.

Change:

• The supplier PDI (EMEA) Limited has informed us of a supply issue with its skin disinfectant biocide.
• There is one product code affected:
  • DEC85019 – Skin Disinfectant BIOCIDE 1.6ml swabstick 2% chlorhexidine in 70% alcohol 50 per pack.
• The supply issue is due to increased demand and lead times.
• Due to this ongoing supply issue this product is now being threshold managed as it is subject to Protect Demand Management.

Impact:

• The affected product is still available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue.
• We are currently sourcing further alternatives and updates will be made to the product listing as soon as possible.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 31 October 2026.

Next Steps:                

• Customers are advised to log into our website to view the potential indirect alternative products and to view the product codes currently subject to Protect Demand Management.
• The continuing supply issue is being monitored in conjunction with the supplier, and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore customers may need to consider clinically reviewing all additional alternatives provided.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure the suitability of these products for your organisation’s use.